Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.09 | 47.63 |
PEG Ratio (TTM) | 0.06 | 0.44 |
P/S Ratio (TTM) | 0.03 | 18.69 |
P/B Ratio (TTM) | 0.00 | 15.94 |
P/FCF Ratio (TTM) | -0.07 | 41.21 |
Price to 5YR AVG Earnings Ratio | N/A | 74.85 |
Price to 5YR AVG FCF Ratio | N/A | 101.28 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.07% | -2.73% |
ROE (TTM) | -0.21% | 9.44% |
Net Profit Margin (TTM) | -0.54% | 4.63% |
ROIC 5YR AVG | N/A | 5.54% |
Growth (2%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -17.84% | N/A | N/A |
Revenue | 1.14% | N/A | N/A |
Net Income | -23.91% | N/A | N/A |
Cash Flow | -57.44% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.02 | 1.88 |
Quick Ratio (TTM) | 0.02 | 1.87 |
D/E Ratio (TTM) | 0.00 | 0.51 |
Interest Coverage (TTM) | -3.71 | 12.85 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 10.68 |
LTL to 5YR AVG FCF | N/A | 4.01 |
Shares Outstanding Growth 5YR AVG | N/A | 50.94% |